×

Biotech exceptionally strong in 2013: Pro

8:24 AM ET Mon, 30 Dec 2013

Discussing the performance of health care and biotech stocks in 2013, and which stocks will continue to gain share, with Mike Weinstein, JPMorgan senior medical technology analyst.